About this trial
The aim of this study was to use MRI imaging to accurately scan the pregnant woman's pelvis and fetal skull, build a 3D model of them, and combine with artificial intelligence to develop an accurate tool to predict the success rate of vaginal delivery.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Full-term.
Single fetus, head first.
Pregnant women have vaginal couvade wishes.
Complete clinical data of pregnant women.
Disqualifiers
Pregnancy with serious medical and surgical diseases.
Abnormal fetal position (such as transverse, breech, etc.).
Twin or multiple pregnancies.
Vaginal couvade contraindications such as placenta previa.
Trial population
Full-term single live pregnant women who gave birth in the Department of Obstetrics of the Second Affiliated Hospital of Wenzhou Medical University from January 1, 2024 to December 31, 2026 were selected as the study population
Trial design
Cohort
Prospective
Treatments tested in this trial
Mri scan of fetal head and pelvis
DeviceThe pelvic parameters and fetal head parameters of pregnant women were measured by MRI, including pelvic entrance plane, middle pelvic plane, pelvic outlet plane, pubic arch Angle, double parietal diameter, occipitofrontal diameter, and suboccipital fontanel diameter.
Treatment groups
Trial outcomes
Primary outcomes
The mode of delivery
Vaginal or cesarean delivery in the end
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: